Pagano, L., Salmanton García, J., Marchesi, F., Blennow, O., Gomes da Silva, M., Glenthøj, A. ... Cornely, O. A. (2022). Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood, 140. (26), 2773-2787. doi: 10.1182/blood.2022017257
Pagano, Livio, et al. "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey." Blood, vol. 140, no. 26, 2022, pp. 2773-2787. https://doi.org/10.1182/blood.2022017257
Pagano, Livio, Jon Salmanton García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap van Doesum, et al. "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey." Blood 140, no. 26 (2022): 2773-2787. https://doi.org/10.1182/blood.2022017257
Pagano, L., et al. (2022) 'Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey', Blood, 140(26), pp. 2773-2787. doi: 10.1182/blood.2022017257
Pagano L, Salmanton García J, Marchesi F, Blennow O, Gomes da Silva M, Glenthøj A, and sur.. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood [Internet]. 2022 December 29 [cited 2025 April 22];140(26):2773-2787. doi: 10.1182/blood.2022017257
L. Pagano, et al., "Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey", Blood, vol. 140, no. 26, pp. 2773-2787, December 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:118019. [Accessed: 22 April 2025]